Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-07

Clinical Trial Update: Effects of rTMS and tDCS Treatment on Brain Function, Craving and Relapse Prevention [NA]

View source ↗

Summary

The trial evaluating rTMS and tDCS for brain function, craving, and relapse prevention in individuals with substance use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Addiction | NA | Status: WITHDRAWN